Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 1
1964 1
1968 2
1970 3
1971 2
1972 2
1974 1
1975 1
1977 1
1980 1
1985 1
1986 1
1988 1
1989 1
1992 3
1993 1
1994 1
1997 3
1998 2
2000 1
2001 2
2002 5
2003 3
2004 5
2005 8
2006 9
2007 1
2008 6
2009 6
2010 7
2011 8
2012 8
2013 5
2014 8
2015 7
2016 14
2017 8
2018 6
2019 6
2020 18
2021 17
2022 20
2023 26
2024 28
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Results by year

Filters applied: . Clear all
Page 1
Malignant phyllodes tumor of the breast: a systematic review.
Lissidini G, Mulè A, Santoro A, Papa G, Nicosia L, Cassano E, Ashoor AA, Veronesi P, Pantanowitz L, Hornick JL, Rossi ED. Lissidini G, et al. Among authors: mule a. Pathologica. 2022 Apr;114(2):111-120. doi: 10.32074/1591-951X-754. Epub 2022 Apr 13. Pathologica. 2022. PMID: 35414723 Free PMC article.
Biological Rhythm and Chronotype: New Perspectives in Health.
Montaruli A, Castelli L, Mulè A, Scurati R, Esposito F, Galasso L, Roveda E. Montaruli A, et al. Among authors: mule a. Biomolecules. 2021 Mar 24;11(4):487. doi: 10.3390/biom11040487. Biomolecules. 2021. PMID: 33804974 Free PMC article. Review.
Dalbavancin in Bone and Joint Infections: A Systematic Review.
Lovatti S, Tiecco G, Mulé A, Rossi L, Sforza A, Salvi M, Signorini L, Castelli F, Quiros-Roldan E. Lovatti S, et al. Among authors: mule a. Pharmaceuticals (Basel). 2023 Jul 15;16(7):1005. doi: 10.3390/ph16071005. Pharmaceuticals (Basel). 2023. PMID: 37513919 Free PMC article. Review.
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.
Foà R, Bassan R, Elia L, Piciocchi A, Soddu S, Messina M, Ferrara F, Lunghi M, Mulè A, Bonifacio M, Fracchiolla N, Salutari P, Fazi P, Guarini A, Rambaldi A, Chiaretti S. Foà R, et al. Among authors: mule a. J Clin Oncol. 2024 Mar 10;42(8):881-885. doi: 10.1200/JCO.23.01075. Epub 2023 Dec 21. J Clin Oncol. 2024. PMID: 38127722 Free PMC article.
Gram-Negative Endogenous Endophthalmitis: A Systematic Review.
Tiecco G, Laurenda D, Mulè A, Arsuffi S, Storti S, Migliorati M, Boldini A, Signorini L, Castelli F, Quiros-Roldan E. Tiecco G, et al. Among authors: mule a. Microorganisms. 2022 Dec 28;11(1):80. doi: 10.3390/microorganisms11010080. Microorganisms. 2022. PMID: 36677371 Free PMC article. Review.
Neuroendocrine neoplasms of the breast: a review of literature.
Vegni F, De Stefano IS, Policardo F, Tralongo P, Feraco A, Carlino A, Ferraro G, Zhang Q, Scaglione G, D'Alessandris N, Navarra E, Zannoni G, Santoro A, Mule A, Rossi ED. Vegni F, et al. Among authors: mule a. Virchows Arch. 2024 Aug;485(2):197-212. doi: 10.1007/s00428-024-03856-y. Epub 2024 Jul 9. Virchows Arch. 2024. PMID: 38980337 Free PMC article. Review.
Beyond the WHO 2020 Classification of Female Genital Tumors: Types of Endometrial Cancer: A Pathological and Molecular Focus on Challenging Rare Variants.
Santoro A, Angelico G, Travaglino A, Inzani F, Arciuolo D, d'Amati A, D'Alessandris N, Scaglione G, Valente M, Urtueta BP, Addante F, Narducci N, Pannone G, Bragantini E, Raffone A, Mulè A, Zannoni GF. Santoro A, et al. Among authors: mule a. Int J Mol Sci. 2024 Sep 25;25(19):10320. doi: 10.3390/ijms251910320. Int J Mol Sci. 2024. PMID: 39408649 Free PMC article. Review.
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study.
Lazzarotto D, Cerrano M, Papayannidis C, Chiaretti S, Mosna F, Fracchiolla N, Zappasodi P, Imbergamo S, Del Principe MI, Lunghi M, Lussana F, Piccini M, Fumagalli M, Dargenio M, Salutari P, Forghieri F, Da Molin TG, Bonifacio M, Olivi M, Giglio F, Trappolini S, Leoncin M, Mule A, Delia M, Pasciolla C, Grimaldi F, Cambo B, Santoro L, Guolo F, Minetto P, Defina M, Chiusolo P, Fanin M, Mauro E, Aprile L, Mazzone C, Trastulli F, Ciccone M, De Gobbi M, Cignetti A, De Bellis E, Mancini V, Piciocchi A, Vignetti M, Marsili G, Starza ID, Fanin R, Luppi M, Ferrara F, Pizzolo G, Bassan R, Foa R, Candoni A. Lazzarotto D, et al. Among authors: mule a. Haematologica. 2025 Jan 1;110(1):55-67. doi: 10.3324/haematol.2024.285638. Haematologica. 2025. PMID: 39157875 Free PMC article.
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting.
Nanni J, Azzali I, Papayannidis C, Mulè A, Audisio E, Martelli MP, Scappini B, Chiusolo P, Cambò B, Candoni A, Lunghi M, Albano F, Olivieri A, Fracchiolla N, Bernardi M, Romani C, Rigolin GM, Giannini MB, Bocchia M, Todisco E, Cilloni D, Bochicchio MT, Ottaviani E, Mattei A, Zamagni F, Valli I, Volpi R, Marconi G, Petracci E; FLAM Collaborative Group; Martinelli G. Nanni J, et al. Among authors: mule a. Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824. Cancer. 2025. PMID: 40159434 Free PMC article.
262 results